Individualizing Dual Antiplatelet Therapy (DAPT) Duration Based on Bleeding Risk, Ischemic Risk, or Both: An Analysis From the DAPT Study
Titel:
Individualizing Dual Antiplatelet Therapy (DAPT) Duration Based on Bleeding Risk, Ischemic Risk, or Both: An Analysis From the DAPT Study
Auteur:
Mihatov, Nino Secemsky, Eric A. Kereiakes, Dean J. Steg, P. Gabriel Cutlip, Donald E. Kirtane, Ajay J. Mehran, Roxana Zhao, Bokai Song, Yang Gibson, C. Michael Yeh, Robert W.